Article

CRYO-ROP 10-year follow-up finds continued benefit

Long-term results from the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity (CRYO-ROP study) are showing continued advantages for treatment in preventing blindness and no long-term disadvantage with reference to acuity.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
Image credit: Ophthalmology Times; Dean McGee Eye Institute resident Ashley Ooms, MD, explores gray area strabismus surgery complications in AUPO poster
J. Peter Campbell, MD, MPH
Expanding accessibility of vision correction with spectacles for children with cranial abnormalities
Elkin: Talking about the importance of pediatric eye health and safety
Identifying 3 barriers keeping families from accessing cataract treatment for their children in India
Related Content
ENTOD Pharmaceuticals announces CDSCO approval of 0.05% atropine drops (Myatro XL)
April 24th 2025

ENTOD Pharmaceuticals announces CDSCO approval of 0.05% atropine drops (Myatro XL)

ROP: Treating and preventing blindness in preterm babies
October 18th 2021

ROP: Treating and preventing blindness in preterm babies

Prevent Blindness urges West Virginia State Legislature to reject bill removing newborn eye infection protection
April 21st 2025

Prevent Blindness urges West Virginia State Legislature to reject bill removing newborn eye infection protection

Managing a changing landscape of IRD pediatric cases
May 10th 2021

Managing a changing landscape of IRD pediatric cases

Early-onset atopic dermatitis linked to higher risk of pediatric uveitis
April 8th 2025

Early-onset atopic dermatitis linked to higher risk of pediatric uveitis

Myopia onset predicted by accelerated eye changes a year in advance
April 2nd 2025

Myopia onset predicted by accelerated eye changes a year in advance

© 2025 MJH Life Sciences

All rights reserved.